ADAM8 and cancer: The ADAM8 Disintegrin (DI) domain mediated TNBC cell adhesion to endothelial cells via activation of integrins on the cancer cell surface that permits intravasation through the blood vessel wall into the blood stream as well as extravasation at distant sites to establish metastases [3].